Eduardo Buitrón is a Legal Director in the Litigation and Health & Life Sciences department at Eversheds Sutherland Madrid office
His professional activity is focused on pre-litigation and dispute resolution, especially in the areas of pharmaceutical, health and IP law (mainly pharmaceutical patents), international and European law. His recent experience in this practice area includes:
- Legal advice and defence in court for a major multinational pharmaceutical company in patent infringement proceedings.
- Advising and defending in court one of the leading international companies in the field of transport and logistics services.
- Legal advice and defence of a multinational phonographic production company (multinational record company) in all international litigation related to the collapse of the roof of the Las Ventas bullring.
Latest Insights
- Article: “The new proposals of commission's new proposals for adaptation of the rules civil liability rules to artificial intelligence and to revise the rules on liability on liability for damage caused by defective products. Defective products. Overview and impact on the the pharmaceutical and health sector.” CEFI, Cuadernos de Derecho Farmacéutico Nº83 (2022)
- Article: “Latest EU measures relating to COVID-19 pandemic – multicentre clinical trials”, International Law Office (ILO, 2020)
- Article: “Latest developments in cross-border preliminary injunctions” (co-author), Lexology UK (2018)
- Article: “TRIPS and the effect of CJEU interpretative rulings on judgments in Spain. Infringement of patents” (co-author), Lexology UK (2016)
- Recognized as “Key Lawyer” in the areas of IP/Patents and Life Sciences , by the prestigious ranking “Legal 500” on their 2024 edition.
- Recognized as “Key Lawyer” in the areas of IP/Patents; Life Sciences; and, Dispute Resolution, by the prestigious ranking “Legal 500” on their 2022 and 2023 edition.
- The Health & Life Sciences department is listed at Chambers & Partners in Band 3 for Life Sciences: Patent Litigation on the 2022 edition.
- The Health & Life Science and the IP: Patents departments have been recognized at Tier 2 by the prestigious ranking “Legal 500” on their 2022 edition.
- The Dispute Resolution practice has been recognized by the prestigious ranking “Legal 500” at Tier 4 in the 2022 edition.
- Recognized as “Team of the Year” by the Forty Under 40 Awards in the category of Health & Life Sciences on its 2021 and 2022 editions.
- Recognized as “Team of the Year” by the IP/TMT Awards in the category of Life Sciences & Pharma on its 2022 edition.
- Legal Director in the Litigation, IP and Life Science Department at Eversheds Sutherland (2023 - Present).
- Senior Associate in the Litigation, IP and Life Science Department at Eversheds Sutherland (2014-2022).
- Legal Director in the pharmaceutical international company Gilead. (secondment) (2021-2022)
- Senior Legal Counsel in the pharmaceutical international company Sandoz (a Novartis Company). (secondment) (2017-2021)
- Lawyer at Gil-Robles & San Bartolomé Associés. Brussels, Belgium (2011-2012).
- Programa de formación ejecutiva del IE - Derecho de la industria farmacéutica por el IE Law School (2019)
- Executive Law Program on Pharmaceutical Industry, IE Law School. Madrid, Spain. (2019)
- Member of the Madrid Bar Association since 2012.
- Training certificate from the College of Europe in Bruges, Belgium.
- Master of Laws (LL.M.) in International Private Law, International Contracts & Commerce, Catholic University of Louvain, Belgium. (2012-2013)
- Master I in Law, Université de Droit Montpellier I, France. (2008-2009)
- Master’s degree in Law, Universidad Carlos III de Madrid, Spain. (2005-2010)